PresseBox
Pressemitteilung BoxID: 592306 (Evotec AG)
  • Evotec AG
  • Manfred Eigen Campus, Essener Bogen 7
  • 22419 Hamburg
  • http://www.evotec.com
  • Ansprechpartner
  • Gabriele Hansen
  • +49 (40) 56081-255

Evotec expands compound management capability to East Coast of the United States

(PresseBox) (Hamburg, Germany, ) Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that Evotec (US) Inc. has executed a multi-year lease on a facility specifically designed to expand the offering of its Compound Management Services on the East Coast of the United States.

The facility, located in Branford Connecticut, is strategically positioned to support the strong presence of Evotec's drug discovery collaborators along the East Coast of the United States. The new facility will be modern, cost effective and scalable for continued growth. The investment into industry leading technologies, specifically aimed at library management, and the access to incremental space will enable Evotec to better support the East Coast pharmaceutical and biopharmaceutical industry for the coming years. The facility will be fully operational early Q3 2013 and will complement the existing facility in South San Francisco which will continue to be fully operational and serve existing clients.

Scott Snyder, Executive Vice President Compound Management of Evotec, commented: 'This is an important strategic expansion of our EVT Execute compound management offering which Evotec first acquired in South San Francisco in 2011. The significant investment will enable Evotec to better compete for East Coast compound management opportunities and continue to provide the very best services and solutions to our partners.'

Contact Evotec AG: Gabriele Hansen, Head of Corporate Communications, Phone: +49.(0)40.56081-255, gabriele.hansen@evotec.com

FORWARD LOOKING STATEMENTS - Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this report. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.